Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G1IF
|
||||
Former ID |
DIB020488
|
||||
Drug Name |
naloxonazine
|
||||
Synonyms |
NSC 612113
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539039] | ||
Structure |
Download2D MOL |
||||
Formula |
C38H42N4O6
|
||||
InChI |
InChI=1S/C38H42N4O6/c1-3-15-41-17-13-35-29-21-5-7-25(43)31(29)47-33(35)23(9-11-37(35,45)27(41)19-21)39-40-24-10-12-38(46)28-20-22-6-8-26(44)32-30(22)36(38,34(24)48-32)14-18-42(28)16-4-2/h3-8,27-28,33-34,43-46H,1-2,9-20H2/b39-23-,40-24-/t27-,28-,33+,34+,35+,36+,37-,38-/m1/s1
|
||||
InChIKey |
AJPSBXJNFJCCBI-HNJBNLCWSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Antagonist | [533906] | |
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.